Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	55,121	76,639	93,403	77,057	66,029	50,990
Market Cap Growth	-34.37%	-17.95%	21.21%	16.70%	29.49%	24.22%
Enterprise Value	40,268	61,056	80,414	66,767	57,309	47,783
Last Close Price	529.24	710.37	875.87	719.50	629.78	481.78
PE Ratio	13.23	17.37	23.63	17.76	8.18	14.51
Forward PE	14.41	15.19	19.36	17.29	11.00	14.28
PS Ratio	4.04	5.40	7.12	6.33	4.11	6.00
PB Ratio	1.91	2.61	3.60	3.40	3.52	4.63
P/TBV Ratio	1.96	2.72	3.75	3.54	3.52	4.63
P/FCF Ratio	17.79	20.91	24.10	17.42	10.11	25.45
P/OCF Ratio	13.96	17.34	20.33	15.37	9.32	19.48
PEG Ratio	1.91	0.95	4.75	-	-	1.55
EV/Sales Ratio	2.86	4.30	6.13	5.49	3.57	5.62
EV/EBITDA Ratio	9.01	13.19	17.28	12.51	6.18	12.25
EV/EBIT Ratio	10.13	14.73	19.00	13.37	6.37	13.04
EV/FCF Ratio	12.98	16.66	20.75	15.09	8.78	23.85
Debt / Equity Ratio	0.09	0.10	0.11	0.12	0.14	0.25
Debt / EBITDA Ratio	0.60	0.63	0.60	0.52	0.29	0.69
Debt / FCF Ratio	0.87	0.80	0.72	0.63	0.41	1.35
Asset Turnover	0.39	0.40	0.42	0.45	0.76	0.53
Inventory Turnover	2.44	2.51	2.51	2.37	2.74	2.26
Quick Ratio	3.90	3.86	4.82	4.16	2.98	2.86
Current Ratio	4.93	4.73	5.69	5.06	3.56	3.63
Return on Equity (ROE)	15.96%	15.95%	16.26%	20.94%	54.21%	31.77%
Return on Assets (ROA)	6.91%	7.31%	8.49%	11.42%	26.39%	14.33%
Return on Capital (ROIC)	8.04%	8.49%	9.76%	13.31%	31.95%	17.95%
Return on Capital Employed (ROCE)	11.70%	12.30%	14.30%	19.20%	41.80%	25.30%
Earnings Yield	8.15%	5.76%	4.23%	5.63%	12.23%	6.89%
FCF Yield	5.62%	4.78%	4.15%	5.74%	9.89%	3.93%
Buyback Yield / Dilution	-0.13%	-1.23%	-0.18%	-1.16%	2.52%	-0.44%

Updated Apr 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q